US antitrust regulators are concerned about health insurer Anthem’sproposed acquisition of Cigna and not sure the companies can offer enough concessions to maintain competition in the industry, The Wall Street Journal reported on Sunday.
Both companies have scheduled meetings this week with top US Department of Justice officials, the Journal reported, citing people familiar with the matter.
Some of the sources said the DOJ had not yet made a decision on whether to sue to block the deal.
Wall Street does not seem convinced the deal will go through, as evidenced in the wide spread between Anthem’s offer and Cigna’s share price. As of the market close on Friday, Cigna shares traded at a 32.5 percent discount to the offer, which has an equity value of about $44 billion.
Anthem announced plans to buy Cigna last summer. Also pending is Aetna’s acquisition of Humana which faces significant antitrust concern, as well. That deal is valued at about $34 billion.
Full Content: Seeking Alpha
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile Faces Class-Action Lawsuit Over Sprint Merger After Appeal Denied
May 16, 2024 by
CPI
Google Faces Backlash Over Introduction of AI-Generated Summaries in Searches
May 16, 2024 by
CPI
CMA Launches Phase 2 Probe into AlphaTheta’s Acquisition of Serato
May 16, 2024 by
CPI
NFL Executive Escapes Testifying in High-Stakes Trial Over Televised Games
May 16, 2024 by
CPI
EU Consumers Lodge Complaint Against Chinese Retailer Temu Over Content Rules Breach
May 16, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI